Crossmark

KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: a systemic review and meta-analysis

Published Online: 2021-03-24

Authors

Peng, Junfu

Lv, Jun

Peng, Jisheng
License Information

Text and Data Mining valid from 2021-03-24

Version of Record valid from 2021-03-24
More Information

Article History

Accepted: 12 March 2021

First Online: 24 March 2021

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare s no competing interests.

Document is current